Advances in B Cell Biology: RA, SLE, and Vasculitis

Advances in B Cell Biology:
RA, SLE, and Vasculitis

Advances in B Cell Biology

Advances in B Cell Biology: RA, SLE, and Vasculitis is a series of CME-accredited webcasts in which expert faculty bridge the gap between the complexities of current immunologic data and how they can be incorporated into clinical practice.

The increasing adoption of B cell-targeted therapies for autoimmune rheumatic diseases (ARDs) into clinical practice challenges clinicians to remain informed regarding data from new and ongoing research studies and clinical trials, especially those presented at national and international meetings. The series is designed for busy clinicians interested in keeping abreast of cutting-edge data and novel therapies in treatment of ARDs – information that can have significant positive impacts on patient outcomes.

Target Audience

This activity is directed to rheumatologists, immunologists, allied health professionals, and other medical professionals who manage patients with rheumatic diseases.

Webcasts - ACR 2011
	Advances in B Cell-Directed Therapies in SLE Richard Furie, MD
	Estimated Time: 45 minutes Release Date: March 28, 2012 Type: Webcast	Technical Requirements: Flash Player Expiration Date: March 28, 2013 Specialties: Rheumatology / Immunology
	Safety of Biologic Therapies Jonathan Kay, MD
	Estimated Time: 30 minutes Release Date: March 30, 2012 Type: Webcast	Technical Requirements: Flash Player Expiration Date: March 30, 2013 Specialties: Rheumatology / Immunology
	Advances in B Cell Therapy for Rheumatoid Arthritis William Rigby, MD
	Estimated Time: 30 minutes Release Date: March 30, 2012 Type: Webcast	Technical Requirements: Flash Player Expiration Date: March 30, 2013 Specialties: Rheumatology / Immunology
	New Perspectives on B Cell Immunobiology and Emerging B Cell Therapies Gregg J. Silverman, MD
	Estimated Time: 30 minutes Release Date: March 30, 2012 Type: Webcast	Technical Requirements: Flash Player Expiration Date: March 30, 2013 Specialties: Rheumatology / Immunology
	Emerging Role of B Cell-Directed Therapies for Vasculitis Leonard H. Calabrese, DO
	Estimated Time: 30 minutes Release Date: March 30, 2012 Type: Webcast	Technical Requirements: Flash Player Expiration Date: March 30, 2013 Specialties: Rheumatology / Immunology
	Advances in B Cell Biology Interactive Case Discussion
	Estimated Time: 30 minutes Release Date: April 4, 2012 Type: Webcast	Technical Requirements: Flash Player Expiration Date: April 4, 2013 Specialties: Rheumatology / Immunology
Webcasts - Post EULAR 2011
	Advances in B Cell Biology: Systemic Lupus Erythematosus Richard Furie, MD
	Estimated Time: 30 minutes Release Date: November 10, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: November 10, 2012 Specialties: Rheumatology / Immunology
	Role of Allied Health Professional: Biologics & Infusions Tiffany Clark, MSN, CNP and Elizabeth Kirchner, MSN, FNP
	Estimated Time: 15 minutes Release Date: November 10, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: November 10, 2012 Specialties: Rheumatology / Immunology
	Emerging Role of B Cell-Directed Therapies of Vasculitis Leonard H. Calabrese, DO
	Estimated Time: 15 minutes Release Date: November 10, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: November 10, 2012 Specialties: Rheumatology / Immunology
	Safety of Biologic Therapies Jonathan Kay, MD
	Estimated Time: 30 minutes Release Date: November 10, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: November 10, 2012 Specialties: Rheumatology / Immunology
	Advances in B Cell Therapy for RA William Rigby, MD
	Estimated Time: 30 minutes Release Date: November 10, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: November 10, 2012 Specialties: Rheumatology / Immunology
	New Perspectives on B Cell Immunobiology and Emerging B Cell Therapies Gregg J. Silverman, MD
	Estimated Time: 30 minutes Release Date: November 10, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: November 10, 2012 Specialties: Rheumatology / Immunology
	Panel Discussion
	Estimated Time: 30 minutes Release Date: December 2, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: December 2, 2012 Specialties: Rheumatology / Immunology

Series Objectives

Summarize recent findings on B cell biology as they apply to understanding the pathophysiology of autoimmune and inflammatory diseases and describe how this knowledge has influenced the development of new and innovative therapeutics utilizing these pathways.
Describe recent clinical trial data on the efficacy and safety of biologic therapeutics targeting B cell pathways in patients with RA.
Describe the role of B cells in the pathogenesis of SLE and assess data from recent clinical trials of biologic therapeutics that target these pathways.
Describe the role of B cells in the pathogenesis of systemic vasculitis and appraise recent clinical trial data on the efficacy and toxicity of traditional and biologic therapies.

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman, Department of Rheumatic and Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Gregg J. Silverman, MD
Co-Director, Musculoskeletal Center of Excellence
Professor of Medicine and Pathology
NYU School of Medicine
New York, NY

RELATED CME CONTENT